Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Policies and Pitfalls: What the Alzheimer's Community Can Learn from the Deployment of Disease-Modifying Therapies for Multiple Sclerosis Patients

Publication ,  Conference
Gupta, I; Kantor, B; Chiba-Falek, O; Angrist, M
Published in: MOLECULAR THERAPY
2021

Duke Scholars

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

2021

Volume

29

Issue

4

Start / End Page

278 / 278

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gupta, I., Kantor, B., Chiba-Falek, O., & Angrist, M. (2021). Policies and Pitfalls: What the Alzheimer's Community Can Learn from the Deployment of Disease-Modifying Therapies for Multiple Sclerosis Patients. In MOLECULAR THERAPY (Vol. 29, pp. 278–278).
Gupta, Ishika, Boris Kantor, Ornit Chiba-Falek, and Misha Angrist. “Policies and Pitfalls: What the Alzheimer's Community Can Learn from the Deployment of Disease-Modifying Therapies for Multiple Sclerosis Patients.” In MOLECULAR THERAPY, 29:278–278, 2021.

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

2021

Volume

29

Issue

4

Start / End Page

278 / 278

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences